

Nariman Javaheri
161 posts

@NarimanJavaher
Gastroenterology/Hepatology Fellow @UBuffalo_GI 🦬💩| Alumni @KansasCityU & @UofT 🦫🧬| Medicine Chief Resident @UBIMResidency |#Kendo ⚔️|#日本語👌🏻| Persian 🦁☀️





🚨 Mass Arrests of Medical Staff; “Crime”: Fidelity to the Medical Oath Field reports indicate an escalation in security crackdowns on physicians who have treated those injured in the protests. Raids on homes and the arrest of doctors are pushing citizens’ access to emergency medical care into crisis. 📍 Some of the detained doctors: •Dr. Alireza Golchini (Surgeon, Qazvin) •Dr. Ameneh Soleimani (Ardabil) •Dr. Farhad Nadali (Surgeon, Gorgan) •Dr. Saber Dehghan (Surgeon, Sirjan) •Dr. Babak Pouramin (Emergency Physician) Under international law, medical personnel are protected in the performance of their professional duties. Treating the wounded is not a “crime.” #IranMassacre








📢New ACG Guideline: Gastric Premalignant Conditions Highlights: 🚨GPMC Dx 🚨endoscopic & nonendoscopic management 🚨histology criteria & reporting 🚨H. pylori eradication 🚨autoimmune gastritis 🚨gastric epithelial polyps Read: bit.ly/acg-gpmc-2025






✨ Thrilled to announce that our abstracts have been accepted to #DDW2025 in beautiful San Diego 🏖️🦭 So grateful for our 🌟-studded team of authors and mentors who were integral in making this happen 💪🏻🔥 @DDWMeeting @ASGEendoscopy @AASLDtweets @SSATNews @AmerGastroAssn








Welcome to TL;DR IBD (or Too Long, Didn't Read IBD), where I post succinct capsule summaries of the latest papers in IBD in 4 minutes, or less In the first episode, I summarize the EXIT trial, which sought to evaluate whether withdrawal of Anti-TNF therapy is a reasonable option for IBD patients in long-term clinical remission Please follow this account and share with your colleagues if you enjoyed this content Link to the article in the comments